Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean Follmann

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
The Journal of Infectious Diseases|March 23, 2021
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome CoronavirusesJoshua G Petrie, Latifa A Bazzi, Adrian B McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 VaccineDean Follmann, Allyson Mateja, Michael P Fay, et al.
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
The Journal of Infectious Diseases|February 18, 2011
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAnuradha Ganesan, Nancy Crum-Cianflone, Jeanette Higgins, et al.
Plos One|March 27, 2012
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV diseaseLotty Ledwaba, Jorge A Tavel, Paul Khabo, et al.
Journal of the American College of Cardiology|September 6, 2003
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trialMichael Domanski, Heidi Krause-Steinrauf, Prakash Deedwania, et al.
Emerging Infectious Diseases|July 25, 2022
Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019Rebekah A Blakney, Emily E Ricotta, Timothy B Frankland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott R Evans, Daniel Rubin, Dean Follmann, et al.
BMC Infectious Diseases|January 22, 2022
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohortRebekah A Blakney, Emily E Ricotta, Dean Follmann, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
The Journal of Infectious Diseases|March 23, 2021
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome CoronavirusesJoshua G Petrie, Latifa A Bazzi, Adrian B McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 VaccineDean Follmann, Allyson Mateja, Michael P Fay, et al.
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
The Journal of Infectious Diseases|February 18, 2011
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAnuradha Ganesan, Nancy Crum-Cianflone, Jeanette Higgins, et al.
Plos One|March 27, 2012
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV diseaseLotty Ledwaba, Jorge A Tavel, Paul Khabo, et al.
Journal of the American College of Cardiology|September 6, 2003
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trialMichael Domanski, Heidi Krause-Steinrauf, Prakash Deedwania, et al.
Emerging Infectious Diseases|July 25, 2022
Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019Rebekah A Blakney, Emily E Ricotta, Timothy B Frankland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott R Evans, Daniel Rubin, Dean Follmann, et al.
BMC Infectious Diseases|January 22, 2022
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohortRebekah A Blakney, Emily E Ricotta, Dean Follmann, et al.
Pageof 15